WASHINGTON, Feb. 17, 2022 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will
release results for the fourth quarter and full year 2021 on
Wednesday, February 23, 2022, after
the market closes.
Vanda will host a conference call at 4:30 PM ET on Wednesday, February 23, 2022, during which
management will discuss the fourth quarter and full year 2021
financial results and other corporate activities. To participate in
the conference call, please dial 1-866-688-9426 (domestic) or
1-409-216-0816 (international) and use passcode 5373895.
The conference call will be broadcast simultaneously and
archived on Vanda's website, www.vandapharma.com. Investors should
go to the website at least 15 minutes early to register, download,
and install any necessary audio software.
A replay of the call will be available on Wednesday, February 23, 2022, beginning at
7:30 PM ET and will be accessible
until Wednesday, March 2, 2022, at
7:30 PM ET. The replay call-in number
is 1-855-859-2056 for domestic callers and 1-404-537-3406 for
international callers. The passcode number is 5373895.
About Vanda Pharmaceuticals Inc.
Vanda is a leading global biopharmaceutical company focused on
the development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda Pharmaceuticals Inc., please visit
www.vandapharma.com and follow us on Twitter @vandapharma.
Corporate Contact:
Kevin
Moran
Senior Vice President, Chief Financial Officer and
Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
Elizabeth Van Every
Head of Corporate Affairs
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com
View original
content:https://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-fourth-quarter-and-full-year-2021-financial-results-on-february-23-2022-301485343.html
SOURCE Vanda Pharmaceuticals Inc.